Comments
Loading...
INmune Bio Earnings Estimates, EPS & Revenue | NASDAQ:INMB | Benzinga
INmune Bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 27
EPS Estimate
$-0.560
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$42.00K
Analyze the earnings history of INmune Bio using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INMB | INmune Bio | -$0.61 | -$0.47 | — | — | $14.00K | — | — | — | 05/08/2025 | Get Alert |
| INMB | INmune Bio | -$0.47 | -$0.56 | — | — | $28.00K | — | — | — | 03/27/2025 | Get Alert |
| INMB | INmune Bio | -$0.48 | -$0.50 | -$0.60 | -20.00% | $43.00K | — | $0.00 | — | 10/31/2024 | Get Alert |
| INMB | INmune Bio | -$0.36 | -$0.63 | -$0.50 | 20.63% | $46.00K | — | $0.00 | — | 08/01/2024 | Get Alert |
| INMB | INmune Bio | -$0.36 | -$0.53 | -$0.61 | -15.09% | $38.00K | $30.00K | $14.00K | -53.33% | 05/09/2024 | Get Alert |
| INMB | INmune Bio | -$0.32 | -$0.44 | -$0.47 | -6.82% | $97.00K | $40.00K | $28.00K | -30.00% | 03/28/2024 | Get Alert |
| INMB | INmune Bio | -$0.43 | -$0.41 | -$0.48 | -17.07% | $98.00K | — | $43.00K | — | 11/01/2023 | Get Alert |
| INMB | INmune Bio | -$0.38 | -$0.40 | -$0.36 | 10.00% | $16.00K | — | $46.00K | — | 08/07/2023 | Get Alert |
| INMB | INmune Bio | -$0.39 | -$0.02 | -$0.36 | -1700.00% | $163.00K | — | $38.00K | — | 05/03/2023 | Get Alert |
| INMB | INmune Bio | -$0.55 | -$0.48 | -$0.32 | 33.33% | $163.00K | — | $97.00K | — | 03/02/2023 | Get Alert |
| INMB | INmune Bio | -$0.55 | -$0.52 | -$0.43 | 17.31% | $14.00K | — | $98.00K | — | 11/02/2022 | Get Alert |
| INMB | INmune Bio | -$0.44 | -$0.50 | -$0.38 | 24.00% | $0.00 | — | $16.00K | — | 08/03/2022 | Get Alert |
| INMB | INmune Bio | -$0.32 | -$0.64 | -$0.39 | 39.06% | $4.00K | — | $163.00K | — | 05/05/2022 | Get Alert |
| INMB | INmune Bio | -$0.24 | -$0.58 | -$0.55 | 5.17% | $10.92K | — | $163.00K | — | 03/03/2022 | Get Alert |
| INMB | INmune Bio | -$0.36 | -$0.38 | -$0.55 | -44.74% | $0.00 | $970.00K | $14.00K | -98.56% | 11/03/2021 | Get Alert |
| INMB | INmune Bio | -$0.20 | -$0.34 | -$0.44 | -29.41% | $0.00 | — | $0.00 | — | 08/04/2021 | Get Alert |
| INMB | INmune Bio | -$0.19 | -$0.27 | -$0.32 | -18.52% | $0.00 | — | $4.00K | — | 05/05/2021 | Get Alert |
| INMB | INmune Bio | -$0.22 | — | -$0.24 | — | $0.00 | — | $10.92K | — | 03/04/2021 | Get Alert |
| INMB | INmune Bio | -$0.28 | -$0.17 | -$0.36 | -111.76% | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| INMB | INmune Bio | -$0.04 | -$0.20 | -$0.20 | 0.00% | $0.00 | — | $0.00 | — | 08/05/2020 | Get Alert |
| INMB | INmune Bio | -$0.20 | -$0.21 | -$0.19 | 9.52% | $0.00 | — | $0.00 | — | 05/14/2020 | Get Alert |
INmune Bio (INMB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-10-31 | $-0.60 | $-0.50 | -20.0 % |
| Q2 | 2024-08-01 | $-0.50 | $-0.63 | 20.6 % |
| Q1 | 2024-05-09 | $-0.61 | $-0.53 | -15.1 % |
| Q4 | 2024-03-28 | $-0.47 | $-0.44 | -6.82 % |
INmune Bio (INMB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2024-05-09 | $14.00K | $30.00K | -53.3 % |
| Q4 | 2024-03-28 | $28.00K | $40.00K | -30.0 % |
| Q3 | 2021-11-03 | $14.00K | $970.00K | -98.6 % |
FAQ
When is INmune Bio (NASDAQ:INMB) reporting earnings?
INmune Bio (INMB) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on October 31, 2024 for Q3.
What were the latest earnings per share (EPS) for INmune Bio (NASDAQ:INMB)?
The Actual EPS was $-0.60, which missed the estimate of $-0.50.
What were INmune Bio’s (NASDAQ:INMB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.